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This paper aims to understand enantioselective transformation of amphetamine, methamphetamine,
MDMA (3,4-methylenedioxy-methamphetamine) and MDA (3,4-methylenedioxyamphetamine) during
wastewater treatment and in receiving waters. In order to undertake a comprehensive evaluation of the
processes occurring, stereoselective transformation of amphetamine-like compounds was studied, for
the ﬁrst time, in controlled laboratory experiments: receiving water and activated sludge simulating
microcosm systems. The results demonstrated that stereoselective degradation, via microbial metabolic
processes favouring S-(þ)-enantiomer, occurred in all studied amphetamine-based compounds in acti-
vated sludge simulating microcosms. R-()-enantiomers were not degraded (or their degradation was
limited) which proves their more recalcitrant nature. Out of all four amphetamine-like compounds
studied, amphetamine was the most susceptible to biodegradation. It was followed by MDMA and
methamphetamine. Photochemical processes facilitated degradation of MDMA and methamphetamine
but they were not, as expected, stereoselective. Preferential biodegradation of S-(þ)-methamphetamine
led to the formation of S-(þ)-amphetamine. Racemic MDMA was stereoselectively biodegraded by
activated sludge which led to its enrichment with R-()-enantiomer and formation of S-(þ)-MDA.
Interestingly, there was only mild stereoselectivity observed during MDMA degradation in rivers. This
might be due to different microbial communities utilised during activated sludge treatment and those
present in the environment. Kinetic studies conﬁrmed the recalcitrant nature of MDMA.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Amphetamine based compounds: amphetamine, metham-
phetamine, MDMA and MDA (Table S1) are characterised as “psy-
choactive substances with stimulant, euphoric, anorectic, and, in
some cases, empathogenic, entactogenic, and hallucinogenic
properties” (Carvalho et al., 2012). The a-methyl group prevents the
oxidation of the amine group by monoamine oxidases increasing
the ability of the molecule to cross membranes, including the
blood-brain barrier resulting in its pharmacokinetics (Young and
Glennon, 1986). Amphetamine based compounds have been used
for several millennia, through the consumption of Catha edulis
(Khat) and various plants in the genus Ephedra (family Ephedraceae)e by Charles Wong.
. Kasprzyk-Hordern).
r Ltd. This is an open access article(Carvalho et al., 2012). Only S-(þ)-amphetamine is prescribed by
the UK National Health Service (NHS) (NHS, 2013). Un-prescribed
use and possession of amphetamine also is illegal, as is posses-
sion or use of all other amphetamine based compounds included
within this article. The quantity of amphetamines (not including
MDMA) seized by UK police and border force agencies increased by
30% to 1.4 tonnes in 2012/13 compared to the previous 12 months
(Coleman, 2013).
Amphetamines have high oral bioavailability, high volume of
distribution, and low plasma protein binding (usually less than
20%) with renal and/or hepatic excretion occurring between 6 and
12 h. Excretion may occur post-hepatic metabolism. However for
several amphetamine based compounds a signiﬁcant proportion is
not biotransformed (Kraemer and Maurer, 2002), meaning the
detection of parent drugs within wastewater is feasible. The
metabolic pathway of amphetamine (Fig. S1) produces a conju-
gated hippuric acid or a conjugated hydroxyamphetamine as the
major metabolites, although hydroxynorephedrine is also a minorunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(þ)-amphetamine, due to its faster metabolism, is shorter than that
of R-()-enantiomer (Cody et al., 2004). Consequently excreted
amphetamine is enriched with R-()-amphetamine. The meta-
bolism of methamphetamine (Fig. S1) into either 4-
hydroxymethamphetamine or into amphetamine is catalysed by
CYP2D6 leading to inter-individual variability (Lin et al., 1997).
Methamphetamine is also poorly metabolised with up to 55%
excreted as the parent drug (de la Torre et al., 2004), with S-
(þ)-methamphetamine having a shorter half-life than that of the R-
()-enantiomer. MDMA (Fig. S2) is extensively metabolised in
humans resulting in only around 20% excreted unchanged (de la
Torre et al., 2004). The two major human metabolic pathways are
through the opening of the methylenedioxy ring followed by
methylation and then phase II conjugation, or the N-dealkylation
into MDA followed by deamination and oxidation (Lim and Foltz,
1989).
The ecotoxicological effects of amphetamines are unknown.
Human toxicological pathways include oxidative and/or nitrodative
stress and neurotoxicity. It is suggested that these may be potential
modes of action in other species. It is also known, through labo-
ratory animal studies, that hepatotoxicity occurs across organisms
(Carvalho et al., 2012).
All amphetamines have been identiﬁed in wastewater, although
to date there are no known regulations addressing the concentra-
tions of illicit drugs in wastewater or receiving environments.
Amphetamine and methamphetamine appear to be readily
degraded (usually >75% removal) during conventional activated
sludge treatment wastewater treatment (Bijlsma et al., 2014; Baker
and Kasprzyk-Hordern. 2013; Huerta-Fontela et al., 2008). This is
reﬂected in very low concentrations found in efﬂuent and receiving
waters and usually not exceeding 20 ng L1 of amphetamine and
100 ng L1 of methamphetamine. However during periods of
higher drug usage (e.g. during a music festival) removal rates
dropped to <15% (Bijlsma et al., 2014) resulting in discharge of
amphetamine into the receiving environment. Compared to other
amphetamine based compounds MDMA has generally poor and
varying removal rates from 12% to 99% (Bijlsma et al., 2012, 2014;
Baker and Kasprzyk-Hordern, 2013; Huerta-Fontela et al., 2008).
This poor and wide removal rate is further exacerbated during high
drug loading in the inﬂuent, e.g. due to a music festival, with rates
dropping to <20% (Bijlsma et al., 2014). Due to poor removal rates
during wastewater treatment, event related high usage of MDMA
and (un)intentional release of unused MDMA (e.g. during police
raid at illegal production facility) into the sewage system might
result in widespread occurrence of MDMA in the receiving
environment.
Degradation of amphetamines is thought to be highly stereo-
selective in wastewater. The limited work undertaken has revealed
that, similarly to human metabolism, microbial metabolic pro-
cesses during wastewater treatment favour S-(þ)-amphetamine
(Kasprzyk-Hordern and Baker, 2012a). Degradation of amphet-
amine and methamphetamine has also been studied in river
simulating microcosm experiments (Bagnall et al., 2013). The ex-
periments demonstrated that under biotic conditions stereo-
selective microbial degradation, which favours S-(þ)-enantiomers,
takes place. The above results could have signiﬁcant ecotoxicolog-
ical consequences as amphetamines are known to have enantio-
mers showing different potency and, potentially, markedly
different ecotoxicity. Research in this area aiming at a full under-
standing of the stereoselective transformation of amphetamines in
the environment is therefore of key importance. This paper aims to
verify enantioselective transformation of amphetamine, metham-
phetamine, MDMA and MDA during wastewater treatment and in
receivingwaters. In order to undertake a comprehensive evaluationof processes occurring, stereoselective transformation of amphet-
amines was studied, for the ﬁrst time, in controlled laboratory ex-
periments - receiving water and activated sludge simulating
microcosm systems.
2. Experimental
2.1. Chemicals and materials
The reference standards: R/S-(±)-amphetamine, R/S-(±)-meth-
amphetamine, R/S-(±)-MDA (3,4-methylenedioxyamphetamine)
and R/S-(±)-MDMA (3,4-methylenedioxy-methamphetamine),
were purchased from LGC Standards (Teddington, UK). All solvents
were of HPLC grade and were purchased from Sigma-Aldrich. All
glassware was silanised with dimethylchlorosilane (5% DMDCS in
toluene, SigmaeAldrich) to minimise sample loss through
adsorption of basic analytes onto -OH sites present on glass surface.
The surrogate/internal standards (IS): R/S-(±)-amphetamine-d11,
R/S-(±)-methamphetamine-d14, R/S-(±)-MDMA-d5, R/S-(±)-MDA-
d5 were purchased from LGC standards (Middlesex, UK). Stock
solutions of each compound (1 mg mL1) were prepared in meth-
anol and stored in the dark at 16 C. Working solutions were
prepared by diluting stock solution in mobile phase and stored
at 16 C.
2.2. Sample collection and storage
Time proportional 24 h composite samples of wastewater were
collected (10 mL every 15 min) using a 3700 portable sampler
(ISCO, Lincoln USA). Recent results have indicated that acidiﬁcation
to pH 4 with hydrochloric acid preserves compounds, with no
signiﬁcant EF change and no mobilisation of the compounds from
solid particles (unpublished results). Therefore pH of each sample
was maintained at 4.0 during sampling, transportation and storage,
and then returned to pH 7 prior to SPE. Grab samples were collected
from the river. All samples were transported back to the laboratory
in cool boxes packed with ice blocks and frozen immediately upon
arrival. Due to equipment failure samples were collected continu-
ously from Thursday 10th July to Sunday 13th July, then restarted
from Monday 21st July to Thursday 24th July.
2.3. Sample preparation
The method has been described in detail by Evans et al. (Evans
et al., 2015). Brieﬂy, liquid samples were ﬁltered and 50 mL sam-
ples were collected and passed through Oasis HLB cartridges
(Waters, UK) at a rate of 6 mL min1 and eluted in 4 mL methanol
under gravity prior to evaporation to dryness. This process was
carried out in duplicate; each duplicate was then reconstituted in
one of the two mobile phases detailed below.
2.4. Sample analysis
All samples were analysed, as described by Evans et al. (2015)
using HPLC performed on Waters ACQUITY UPLC® system (Wa-
ters, Manchester, UK). The chiral separation was carried out with
the use of two columns. The CBH, an enzyme based column packed
with Cellobiohydrolase (100 2 mm, 5 mm, Sigma Aldrich, UK) was
run isocratically with 90:10 water:isopropanol, 1 mM ammonium
acetate at a rate of 0.075 mL min1. Each injection was 20 mL.
All analytes were identiﬁed and quantiﬁed using a Xevo TQD
Triple Quadrupole Mass Spectrometer (Waters, UK), equipped with
an electrospray ionisation source in positive ion mode. Nitrogen
was used as the nebulising and desolvation gas, supplied by a high
purity nitrogen generator (Peak Scientiﬁc, UK). Argon (99.998%)
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sLynx 4.1 (Waters, UK) was used to control the Waters ACQUITY
system and the Xevo TQD. Optimised MS parameters were as fol-
lows: the capillary voltage set at 3.49 kV, source temperature at
150 C, desolvation gas ﬂow at 300 L h1. Nitrogen was used as
nebulising and desolvation gas, while argon was used as a collision
gas. MassLynx 4.1 (Waters, UK) was used to control the Waters
ACQUITY system and the Xevo TQD. Data processing was carried
out on TargetLynx software (Waters, Manchester, UK) (Evans et al.,
2015).
2.5. Quantiﬁcation and conﬁrmation
Each compound was quantiﬁed bymultiple reaction monitoring
(MRM), using the protonated molecular ion as the precursor ion.
The most abundant transition product ion was used to quantify,
whilst conﬁrmation was carried out using the lesser abundant
product ion (Table S2). In addition the ratio of quantiﬁer to
conﬁrmatory ion was used according to limits set by EC guidelines
(2002). Deuterated surrogate/internal standards were used to
compensate for ion suppression/enhancement, loss during sample
preparation and/or stereoselective mechanisms during sample
preparation (Evans et al., 2015).
Enantiomeric fractions were calculated using Equation (1)
(Evans et al., 2015).
EF ¼ ð þ Þð þ Þ þ ð  Þ (1)
Where: EF denotes enantiomeric fraction, (þ) denotes concentra-
tion of S-(þ)-enantiomer and () indicates concentration of R-
()-enantiomer, in relation to the compounds targeted within this
paper. An EF > 0.5 therefore indicates an enrichment of the S-
(þ)-enantiomer and EF < 0.5 indicates an excess of R-
()-enantiomer.
Full validation data are presented in Tables S3e4 and are
described in detail elsewhere (Evans et al., 2015).
2.6. Full scale study
In order to verify stereoselective transformation of chiral drugs
during wastewater treatment and in receiving waters, a large
WWTP3 serving 910 thousand people and a 33 km long stretch of a
river were monitored. The river was sampled in July 2011; four
sampling points were chosen: location R1 and R2 (upstream and
downstream from two discharges from small WWTPs 1&2
respectively), location R3 and location R4 (Fig. 1). Grab samples
were collected in the morning and afternoon for 1 week from four
river sites whose locations in relation to the WWTPs can be seen in
Fig. 1. A monitoring campaign of WWTP3 was undertaken in July
2014, with time proportional samples collected from three loca-
tions: after screens (locationW1), after settling tanks (locationW2)
and after activated sludge treatment (locationW4). Grab samples of
the activated sludge reactors were collected at location W3 at the
WWTP (Fig. 1). Main characteristics of the WWTP are provided in
Table S5.
2.7. Microcosms
River microcosms were carried out with water collected from
location R1 shown in Fig.1. Receivingwatermicrocosmswere 90:10
river water (also collected from location R1): WWTP efﬂuent.
Activated sludge microcosms were set up with activated sludge
taken during themixing phases of the batch reactors (locationW3).
River and receiving water microcosms were carried out in 2 Lcylindrical ﬂasks under continuous mixing with magnetic stirrers.
Each ﬂask was kept under speciﬁc conditions of either dark
(wrapped in foil), light (exposed to an Osram 400 W HQI BT
daylight lamp for 12 h per day, through borosilicate 3.3 glass with
no visible light absorption and UV light cut-off at <275 nm, in-
tensity was measured as 320 mmol/S/m2) and biotic or abiotic
(sterilised with 1 g L1 sodium azide). All reactors had cotton wool
stoppers and were agitated by magnetic stirrers to maintain high
O2 levels. Samples were collected every day for 2 weeks. Dissolved
oxygen, pH and temperature were measured daily. Dissolved oxy-
gen was in the range of 7e8 mg L1. The pH ranged between 8 and
9. Temperature of microcosms was within the range: 21e29 C.
Activated sludge microcosms were carried out in 2 L cylindrical
ﬂasks with air pumped to below the surface of the liquid. All re-
actors were kept in the dark with rubber bungs to allow controlled
provision of air and exhausts to be ﬁltered. Magnetic stirrers were
employed to prevent stratiﬁcation. Eleven samples were collected
over 24 h. Physicochemical parameters of wastewater such as
ammoniacal nitrogen, nitrate, nitrite and chemical oxygen demand
are provided in Table S5.
Microcosms were carried out in duplicate and were either
spiked with a single compound or with a mixture of compounds.
2.8. Kinetics e activated sludge simulating microcosms
The compounds studied are characterised as having low vola-
tility and therefore volatilisation was not considered as a potential
removal pathway in studied microcosms. Photodegradation was
also not considered (not relevant) under tested activated sludge
conditions. Therefore the two important degradation mechanisms
to consider were biodegradation and sorption to sludge. Sorption of
studied compounds was previously reported as <10% (Baker and
Kasprzyk-Hordern, 2011) and therefore could be considered
negligible. Several reports utilised pseudo-ﬁrst-order kinetics for
degradation of micropollutants in activated sludge reactors (Joss
et al., 2006; Suarez et al., 2010; Collado et al., 2012). Indeed when
applying pseudo-ﬁrst order kinetics (OECD 303) in this work, ln(Ce/
Ci) plotted as a function of time yielded a straight line (R2 > 0.9).
Pseudo-ﬁrst order biodegradation rate k1 [L g1h1] (normalised
for concentration of suspended solids) was therefore calculated
using the following formula (Equation (2)):
ln
Ce
Ci
¼ k1*t*SS (2)
where: t ¼ aeration time (24 h), Ce ¼ concentration at time point t
(mg L1), Ci ¼ initial concentration (mg L1), SS ¼ concentration of
activated sludge solids (g L1).
3. Results and discussion
3.1. Occurrence and fate of chiral amphetamines in receiving waters
and during wastewater treatment
3.1.1. Occurrence of chiral amphetamine-like drugs in rivers
The environmental monitoring programme carried out in a large
river in the UK showed no quantiﬁable results for amphetamine or
methamphetamine. On the other hand, MDMA was found to be
ubiquitous in the receiving waters (Fig. 2). Concentrations did
generally rise in the river downstream from WWTP1 and 2
discharge points until the extreme dilution experienced in the tidal
area (location R4). The enantiomeric fraction of MDMA was
consistently below 0.3, showing a persistence of the R-()-enan-
tiomer in the aqueous environment. This is in agreement with
excretion patterns by humans and with the values reported by
Fig. 1. Sampling locations from river and WWTP3 sampling campaigns.
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(þ)-MDAwas identiﬁed in analysed samples. This is most probably
due to metabolism of MDMA, which favours degradation of S-
(þ)-MDMA leading to the formation of S-(þ)-MDA. This indicates
that MDA present in analysed environmental samples is due to the
metabolism of MDMA and not as a result of illegal use of MDA. In
the case of illegal use, MDA in the environmental matrix would be
either enriched with R-()-enantiomer (due to stereoselective
metabolism of MDA favouring S-(þ)-enantiomer or it would
remain racemic (because MDA is distributed as racemate)
(Kasprzyk-Hordern and Baker, 2012a, 2012b). As enantiomers of
MDA and MDMA are known to have different pharmacological
actions (e.g. according to Marquardt et al., 1978) S-(þ)-MDA be-
haves more like the stimulant amphetamine and R-()-MDA be-
haves more like the hallucinogen LSD) there is high probability that
two enantiomers of MDA or MDMA will trigger different (poten-
tially toxic) biological responses in the environment. Detailedecotoxicological studies are therefore required to verify the signif-
icance of stereoselective degradation of these drugs.3.1.2. Occurrence and fate of chiral amphetamine-like drugs during
wastewater treatment
The 24-composite wastewater inﬂuent samples from WWTP3
showed consistently quantiﬁable concentrations of amphetamine
with an average EF ¼ 0.6 (Fig. 3) indicating its enrichment with S-
(þ)-enantiomer. The drug persisted through the settling process;
however the concentration drastically dropped during activated
sludge treatment. The EF was found to decrease to racemic. The EF
of amphetamine continued to decrease slightly as the activated
sludge process continued and the wastewater was transferred for
discharge containing amphetamine with EF of 0.4 indicating
enrichment of amphetamine with R-()-enantiomer. This is an
outcome of signiﬁcant importance showing that enantiomeric
composition of amphetamine could be reversed during activated
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cological importance as an assumption is usually made during
environmental risk assessment that drugs remain in the environ-
ment in the same enantiomeric form as marketed. The WWTP
process was found to be effective with the removal of 93% ± 2% of
amphetamine (accounting for 95% ± 1% and 89% ± 4% removal of S-
(þ)- and R-()-amphetamine respectively) from wastewater.
Methamphetamine was detected at relatively low concentra-
tions (<50 ng L1) in wastewater (Fig. 3). It was mostly enriched
with potent S-(þ)-enantiomer in raw wastewater. The range of
removal rates for methamphetamine was found to be relatively
large: 23% ± 88%. Stereoselectivity in the removal was observed and
led, similarly to amphetamine, to an enrichment of methamphet-
amine with R-()-enantiomer.
MDMAwas the most prevalent of all the illicit drugs targeted in
wastewater inﬂuent with concentrations exceeding 1 mg L1
(Fig. 3). This supports the literature data suggesting that this is a
relatively popular drug within the UK. Its concentration was higher
in the weekend samples, which is to be expected from a recrea-
tional drug. The concentration of MDMA was also higher in the
settled wastewater than in the inﬂuent, which was unexpected and
cannot be explained at this stage. MDMA was also detected in the
efﬂuent. The settling process was found not to change the EF of
MDMA. However, the activated sludge process showed high ster-
eoselectivity and resulted in an enrichment of MDMA with R-
()-enantiomer which is in agreement with the EF recorded in
receiving waters. The removal rate of MDMA was on average
40% ± 24% and is mainly attributed to the removal of S-(þ)-MDMA
(mean removal for S-(þ)- and R-()-MDMA was 53% ± 29% and
1% ± 20% respectively). This poor removal concurs with the litera-
ture values which have been reported previously (Bijlsma et al.,
2012, 2014; Baker and Kasprzyk-Hordern, 2013; Huerta-Fontela
et al., 2008). The above indicates that removal of MDMA isattributed to S-(þ)-MDMA. R-()-MDMA is not degraded under the
studied conditions and therefore it should be considered as a
pollutant of recalcitrant nature.
MDAwas also detected inwastewater (Fig. 3). The concentration
proﬁle appears to mirror MDMA concentrations with peaked con-
centrations falling towards the end of the weekend and just after.
The concentration of MDA increased sharply between the inﬂuent
and the activated sludge stage, indicating that MDA is produced by
the breakdown of MDMA considering the complementary reduc-
tion in concentration of this compound during the same time
frame. The EF of MDA in inﬂuent and settled wastewater tends to be
in excess of 0.5. This is to be expected considering the anticipated
human metabolic pathway of MDMA, favouring S-(þ)-enantiomer
and leading to the formation of S-(þ)-MDA. However, activated
sludge treatment brings this enantiomeric fraction, due to micro-
bial activity, to below 0.5, most likely through the preferential
degradation of S-(þ)-MDA. This is contradictory to the data gath-
ered from the July river water samples which only detected S-
(þ)-MDA. The overall increase of S-(þ)- and R-()-MDA during
activated sludge treatment accounted for 89% ± 35% and
254% ± 69% respectively, which conﬁrms the recalcitrant nature of
R-()-MDA.3.2. River (and receiving waters) and activated sludge simulating
microcosms
In order to study the mechanisms of transformation and to
understand which processes are responsible for stereoselective
degradation of amphetamines, several river, receiving waters and
activated sludge simulating microcosms were undertaken under
controlled laboratory conditions. The following phenomena were
studied: microbial metabolic transformation (in dark and light bi-
otic reactors e DBRs and LBRs), photolysis (in light biotic and light
S.E. Evans et al. / Environmental Pollution 215 (2016) 154e163 159abiotic reactors e LBRs and LARs) and other physicochemical pro-
cesses, e.g. hydrolysis, sorption (in dark and light abiotic reactors e
DARs and LARs).
3.2.1. MDMA
3.2.1.1. River and receiving water microcosms. The results of the
mixed-compound river water microcosms (Fig. S3) indicated that
MDMA was only slightly degraded (<50%) over the course of two
weeks in abiotic conditions both in the presence and absence of
light (see DAR and LAR reactors in Fig. S3). On the other hand,
microbial degradation in the presence of light led to the complete
removal of MDMA within the two weeks study period (see LBR
reactor in Fig. S3). Only slight stereoselectivity was observed in
biotic conditions in the second week of the experiment and led to
the enrichment of MDMA with R-()-enantiomer.
Microbial metabolic degradation in the presence of light was
also the most successful in removing MDMA in the mixed-
compound receiving water microcosms (see DBR and LBR re-
actors in Fig. 4), although photolysis was also found to reduce the0
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Fig. 4. Mixed-compound receiving waters microcosms eMDMA, MDA, amphetamine and m
(concentrations are represented by bars, enantiomeric fractions are represented by symbols)
dark biotic (DBR), light abiotic (LAR), light biotic (LBR), dark anoxic abiotic (DAAR) and darconcentration of MDMA by approximately 80% over the twoweeks.
The microorganisms did not degrade MDMA under anoxic condi-
tions (see DABR reactor in Fig. S4). The biological degradation
resulted in only slight enrichment of MDMA with R-()-enan-
tiomer under dark biotic conditions in the second week of the
experiment.
3.2.1.2. Activated sludge microcosms. In contrast to the river-water
microcosms, the mixed-compound activated sludge microcosms
resulted in high stereoselectivity of microbial metabolic degrada-
tion (Fig. 5). Due to faster degradation of S-(þ)-MDMA, which was
almost completely removed in 9 h, a signiﬁcant dominance of R-
()-MDMA would be expected to be present in efﬂuent discharges
considering the 16 h activated sludge retention time (as observed at
the sampled WWTP).
The single-compound activated sludge microcosm conﬁrmed
that stereoselectivemicrobial metabolism favours degradation of S-
(þ)-MDMA with the formation of S-(þ)-MDA (Fig. 6a). No degra-
dation of R-()-MDMA was observed during the 24 h duration of 
 
  
  
0
0.2
0.4
0.6
0.8
1
0
200
400
600
800
1000
0 2 4 6 8 10 12 14
Co
nc
en
tr
aƟ
on
 (n
g 
L
)
Time [day]
AMPH - LBR
En
an
Ɵo
m
er
ic
 fr
ac
Ɵo
n
0
0.2
0.4
0.6
0.8
1
0
200
400
600
800
1000
0 2 4 6 8 10 12 14
En
an
Ɵo
m
er
ic
 fr
ac
Ɵo
n
Co
nc
en
tr
aƟ
on
 [n
g/
L]
Time [day]
METH - LBR
0
0.2
0.4
0.6
0.8
1
0
200
400
600
800
1000
0 2 4 6 8 10 12 14
En
an
Ɵo
m
er
ic
 fr
ac
Ɵo
n
Co
nc
en
tr
aƟ
on
 (n
g 
L
)
Time [day]
MDMA - LBR
0
0.2
0.4
0.6
0.8
1
0
200
400
600
800
0 2 4 6 8 10 12 14
En
an
Ɵo
m
er
ic
 fr
ac
Ɵo
n
Co
nc
en
tr
aƟ
on
 (n
g 
L
)
Time [day]
MDA - LBR
ethamphetamine degradation under dark biotic (DBR) and light biotic (LBR), conditions
. Note: See Figs. S4eS7 for results from all studied microcosm conditions: abiotic (DAR),
k anoxic biotic (DABR) conditions.
  
0
0.2
0.4
0.6
0.8
1
0
500
1000
1500
2000
0
2.
5 5
7.
5 10
12
.5 15
17
.5 20
22
.5
En
an
Ɵo
m
er
ic
 F
ra
cƟ
on
Co
nc
en
tr
aƟ
on
 (n
g 
L-1
)
Time [h]
AMPH
0
0.2
0.4
0.6
0.8
1
0
500
1000
1500
2000
2500
3000
3500
0
2.
5 5
7.
5 10
12
.5 15
17
.5 20
22
.5
En
an
Ɵo
m
er
ic
 F
ra
cƟ
on
Co
nc
en
tr
aƟ
on
 (n
g 
L-1
)
Time [h]
METH
0
0.2
0.4
0.6
0.8
1
0
500
1000
1500
2000
2500
3000
3500
0
2.
5 5
7.
5 10
12
.5 15
17
.5 20
22
.5
En
an
Ɵo
m
er
ic
 F
ra
cƟ
on
Co
nc
ne
tr
aƟ
on
 (n
g 
L-1
)
Time [h]
MDA
0
0.2
0.4
0.6
0.8
1
0
500
1000
1500
2000
2500
0 2 4 6 8 1012141618202224
En
an
Ɵo
m
er
ic
 F
ra
cƟ
on
Co
nc
en
tr
aƟ
on
 (n
g 
L-1
)
Time [h]
MDMA
Fig. 5. Mixed-compound activated sludge microcosms e MDMA, MDA, amphetamine and methamphetamine degradation under dark biotic (DBR) conditions (concentrations are
represented by bars, enantiomeric fractions are represented by symbols). (a) MDMA degradation and MDA formation in single-compound activated sludge microcosms. (b) AMPH
degradation in single-compound activated sludge microcosms. (c) METH degradation and AMPH formation in single-compound activated sludge microcosms.
S.E. Evans et al. / Environmental Pollution 215 (2016) 154e163160the microcosm experiment. An increase of MDA concentration
aligned with a decrease of MDMA concentration further supports
our hypothesis. Interestingly, MDA's enantiomeric fraction was
found to decrease in time from 0.92 to 0.62, which might suggest
that S-(þ)-MDA, formed as a by-product of MDMA metabolism, is
subsequently preferentially metabolised, which then leads to the
enrichment of MDA with R-()-enantiomer.
The above results are of signiﬁcance regarding the fate and
possible effects of MDMA in the aqueous environment. Based on
our results, there is only mild stereoselectivity observed during
MDMA degradation in rivers. However, a pronounced stereo-
selective biodegradation favouring degradation of S-(þ)-MDMA
and formation of S-(þ)-MDA is observed in activated sludge
simulating microcosms. This might be due to the different micro-
bial communities utilised during activated sludge treatment and
those present in the environment. MDMA is produced as a race-
mate but due to human metabolism and then microbial metabolic
processes during wastewater treatment it becomes enriched with
R-()-enantiomer. Kinetic studies (Table 1) conﬁrmed the recalci-
trant nature of MDMA. kbiol and t1/2biol of S-(þ)-MDMA degradation
were 1.36 LgSS1 h1 and 0.51 h respectively. Due to the lack of
degradation of R-()-MDMA no kinetic studies could be
undertaken.
3.2.2. MDA
3.2.2.1. River and receiving waters microcosms. MDA was not
degraded under abiotic and/or anoxic conditions in the mixed-
compound receiving water microcosm, as shown in Fig. S5. Aero-
bic biological degradation did signiﬁcantly degrade MDA and
resulted in an excess of S-(þ)-MDA in dark conditions, although not
signiﬁcantly in light conditions. Photochemical processes were not
found to degrade either enantiomer, so this difference in enantio-
meric fractions between biotic light and biotic dark is thought to be
due to the development of different microorganism populations
and/or different metabolic pathways utilised in the differing con-
ditions. Increased formation of S-(þ)-MDA in dark biotic conditionswithin the second week is likely to be associated with metabolism
of MDMA showing slight preference towards S-(þ)-enantiomer
under the same conditions (see Fig. 4 and Fig. S4).
3.2.2.2. Activated sludge microcosms. Interestingly, in the mixed-
compound activated sludge microcosms (Fig. 5) MDA did not
appear to be degraded, although a signiﬁcant enantiomeric fraction
change was observed. This might be the result of two processes
occurring: degradation of racemic MDA (spiked into the micro-
cosm) and formation of S-(þ)-MDA as a result of metabolism of S-
(þ)-MDMA.
3.2.3. Amphetamine
3.2.3.1. River water and receiving waters microcosms. The results of
the mixed-compound receiving waters microcosm indicated that
amphetamine is not degraded by abiotic processes (see DAR and
LAR reactors in Fig. S6). However, aerobic biological degradation
did not require light and resulted in almost complete degradation
of amphetamine in 10 days (see DBR reactor in Fig. 4). Within 3
days, only R-()-amphetamine remained in the solution. Under
light conditions amphetamine appears to have been produced in
the second week of the experiment, possibly from the degradation
of methamphetamine. Anoxic conditions were able to support
microorganisms which did degrade amphetamine, although only
by approximately 40%. A slight excess of R-()-amphetamine was
also noted in one of the microcosms under dark anoxic biotic
conditions.
Results of the single-compound receiving waters microcosm
indicated complete degradation of amphetamine in under 3 days in
light and under a week in the dark (Fig. 7a). In both cases the S-
(þ)-amphetamine was degraded ﬁrst, resulting in an enantiomeric
fraction of close to 0 prior to complete removal. These results are in
agreement with previous results published by Bagnall et al. (2013).
3.2.3.2. Activated sludge microcosms. The mixed-compound acti-
vated sludge wastewater microcosms, as shown in Fig. 5, indicated
(a) MDMA degradaƟon and MDA formaƟon in single-compound acƟvated sludge microcosms 
(b) AMPH degradaƟon in single-compound acƟvated sludge microcosms 
(c) METH degradaƟon and AMPH formaƟon in single-compound acƟvated sludge microcosms 
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Fig. 6. Single-compound (a) MDMA, (b) AMPH and (c) METH activated sludge microcosms under dark biotic (DBR) and dark abiotic (DAR) conditions (concentrations are repre-
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S.E. Evans et al. / Environmental Pollution 215 (2016) 154e163 161that S-(þ)-amphetamine is preferentially degraded which led to
the enrichment of amphetamine with R-()-enantiomer. Forma-
tion of small quantities of S-(þ)-amphetamine at the later stage of
the microcosm experiment might be because of preferential
degradation of S-(þ)-methamphetamine.
In single-compound activated sludge microcosms, amphet-
amine spiked into sterile conditions did not signiﬁcantly degrade
amphetamine, as shown in Fig. 6b (see DAR reactor). However,
biological processes were found to be responsible for rapid and
stereoselective degradation resulting in only R-()-amphetamine
within 6 h. Kinetic studies (Table 1) conﬁrmed, as in the case of
MDMA and MDA, the more recalcitrant nature of R-()-enantiomer. kbiol of R-()-amphetamine degradation was
0.52 LgSS1 h1, which is ﬁve times lower than kbiol of S-
(þ)-amphetamine (2.76 LgSS1 h1).
3.2.4. Methamphetamine
3.2.4.1. River and receiving waters microcosms. In mixed-
compound receiving water microcosms, methamphetamine
degradation was limited and was only observed under biotic con-
ditions (see DBR and LBR reactors in Fig. 4). Microbial metabolic
processes did not show high stereoselectivity, although a slight
excess of R-()-methamphetamine was observed in the second
week of the experiment.
Table 1
Degradation pseudo-ﬁrst order rate constants (k1 and kbiol) in single-compound activated sludge simulating microcosms.
R2 SS [g L1] k1 [h1] t1/2 [h] kbiol [L gSS1 h1] t1/2biol [h]
(±)-Amphetamine y ¼ 0.1988x0.1982 0.9688 0.25 0.20 3.49 0.81 0.85
S-(þ)-Amphetamine y ¼ 0.6759x0.4784 0.9544 0.25 0.68 1.03 2.76 0.25
R-()-Amphetamine y ¼ 0.1269x0.0394 0.8947 0.25 0.13 5.46 0.52 1.34
(±)-Methamphetamine n/a
S-(þ)-Methamphetamine y ¼ 0.0484x þ 0.4938 0.9075 0.25 0.05 14.3 0.20 3.50
R-()-Methamphetamine No degradation
(±)-MDMA n/a
S-(þ)-MDMA y ¼ 0.1319x þ 0.3034 0.9522 0.10 0.13 5.26 1.36 0.51
R-()-MDMA No degradation
n/a - not calculated due to no degradation of R-()-enantiomer.
(a) Amphetamine degradaƟon in single-compound receiving waters microcosms 
(b) Methamphetamine degradaƟon in single-compound receiving waters microcosms
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S.E. Evans et al. / Environmental Pollution 215 (2016) 154e163162However, in the single-compound receiving water microcosms
(Fig. 7b) a pronounced stereoselectivity was observed in dark biotic
conditions. This is despite lower removal rate of methamphetamine
in dark biotic conditions as opposed to light biotic conditions.
Amphetamine was produced as a product of this degradation,
however at relatively small amounts. Bagnall et al. (2013) also
found that stereoselective degradation preferentially degraded S-
(þ)-methamphetamine, although this was noted in both light and
dark reactors.3.2.4.2. Activated sludge microcosms. The mixed-compound acti-
vated sludge wastewater microcosms (Fig. 5) led to almost com-
plete removal of S-(þ)-methamphetamine in 9 h, suggesting a
signiﬁcant dominance of R-()-enantiomers would be present in
efﬂuent discharges considering the 16 h activated sludge retention
time exhibited at the sampled WWTP.
Similar results were observed in the case of single-component
activated sludge microcosms (Fig. 6c). Signiﬁcant S-(þ)-amphet-
amine production occurred under biotic conditions. This is to be
expected due to the preferential microbial metabolic degradation ofS-(þ)-methamphetamine. It should be noted that amphetamine
formationwas also observed in the abiotic reactor, which cannot be
explained at this stage. Kinetic studies (Table 1) conﬁrmed themore
recalcitrant nature of R-()-methamphetamine. kbiol and t1/2biol of
S-(þ)-methamphetamine degradation were 0.20 LgSS1 h1 and
3.60 h respectively. Due to the lack of degradation of R-()-meth-
amphetamine no kinetic studies could be undertaken.4. Conclusions
The aim of this paper was to verify enantioselective trans-
formation of amphetamine, methamphetamine, MDMA and MDA
during wastewater treatment and in receiving waters in controlled
laboratory experiments - receiving water and activated sludge
simulating microcosm systems. The results demonstrated that
stereoselective degradation, via microbial metabolic processes
favouring S-(þ)-enantiomer, occurred in all studied amphetamine-
based compounds in activated sludge simulating microcosms. R-
()-enantiomers were not degraded (or their degradation was
limited) which proves their more recalcitrant nature. Out of all four
S.E. Evans et al. / Environmental Pollution 215 (2016) 154e163 163amphetamine-like compounds studied, amphetamine was the
most susceptible to biodegradation. It was followed by MDMA and
methamphetamine. Photochemical processes facilitated degrada-
tion of MDMA and methamphetamine but they were not, as ex-
pected, stereoselective.
Strong enantioselective degradation of amphetamine in favour
of S-(þ)-amphetamine was demonstrated in all environments.
Preferential biodegradation of S-(þ)-methamphetamine led to the
formation of S-(þ)-amphetamine. Racemic MDMA was stereo-
selectively biodegraded in activated sludge, which led to its
enrichment with R-()-MDMA and formation of S-(þ)-MDA.
Interestingly, there was only mild stereoselectivity observed during
MDMA degradation in rivers. This might be due to different mi-
crobial communities utilised during activated sludge treatment and
those present in the environment. Kinetic studies conﬁrmed the
recalcitrant nature of MDMA.
To summarise, all the amphetamine based compounds studied
here are stereoselectively metabolised by humans to produce an
excreted product enriched with the R-()-enantiomers. Any ster-
eoselective degradation carried out by organisms either in the
treatment process or in the receiving environments has also been
preferentially degrading the S-(þ)-enantiomer in all the com-
pounds studied here. Unfortunately, their enantiomer-speciﬁc
ecotoxicity has never been documented. However, considering
the toxicological pathways which they exhibit within humans it
would be thought that a wide variety of organisms may be
vulnerable to their toxic effects at relatively low concentrations.
Toxicity tests, particularly those which identify enantiomer-speciﬁc
and/or synergistic pathways, need to be carried out to assess the
risk to receiving environments. This is of particular importance in
the case of MDMA which is readily quantiﬁed in rivers around the
world due to its poor removal rates and high usage.
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